Danaher Corporation (DHR) Position Maintained by Clear Harbor Asset Management LLC

Clear Harbor Asset Management LLC continued to hold its stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,686 shares of the conglomerate’s stock at the end of the second quarter. Clear Harbor Asset Management LLC’s holdings in Danaher Corporation were worth $308,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Peddock Capital Advisors LLC raised its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the period. Proficio Capital Partners LLC raised its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares during the period. ClariVest Asset Management LLC bought a new stake in shares of Danaher Corporation during the first quarter worth about $157,000. Motco raised its stake in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the period. Finally, Baystate Wealth Management LLC raised its stake in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the period. Institutional investors and hedge funds own 76.12% of the company’s stock.

Danaher Corporation (NYSE:DHR) traded up 0.36% on Friday, reaching $81.20. 1,246,894 shares of the company’s stock traded hands. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The firm’s 50-day moving average is $82.41 and its 200 day moving average is $84.22. The stock has a market capitalization of $56.41 billion, a PE ratio of 25.92 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same period last year, the firm posted $0.90 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. Analysts forecast that Danaher Corporation will post $3.95 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://sportsperspectives.com/2017/08/18/danaher-corporation-dhr-position-maintained-by-clear-harbor-asset-management-llc.html.

A number of equities research analysts recently weighed in on DHR shares. Deutsche Bank AG reaffirmed a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a research report on Wednesday, June 21st. Credit Suisse Group reaffirmed a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research report on Wednesday, May 24th. BTIG Research reaffirmed a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research report on Sunday, April 23rd. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a research report on Friday, July 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation has a consensus rating of “Buy” and an average price target of $91.76.

In related news, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock valued at $3,206,426 over the last three months. 12.20% of the stock is currently owned by insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply